Skip to main content

Table 1 Description of the eleven patients with unexpected positive intraoperative culture

From: Antibiotic therapy alone does not have a high success rate in cases of unexpected positive cultures in intraoperative samples from hip and knee prosthesis revision

Pat. Gen-der BMI ASA CCI Joint Histo-ry Joint Number previous opera-tions at the joint including arthropl. CRP Pre-biopsy (mg/L) WBC count in synovia
(cells/μL)
Micro-biology Biopsy Histology Biopsy ICM-Score pre-op Micro-biology Revision Histo-logy Re-vision ICM-Score after revi-sion Antibiotic Therapy Re-infection after months
1 male 25.4 2 0 TKA Loose-ning after 6 years 1 21 1360 neg. neg. 2 Staph. hominis (3/5) neg. major + 2 Flucloxacillin + Rifampicin 2 weeks then Levofloxacin + Rifampicin 4 weeks 36 months with Staph. hominis
2 fem. 28.1 2 0 TKA Revi-sion after 3 years because of arthro-fibrosis 3 <  5 800 neg. neg. 0 Staph. epidermidis (3/5)
Staph. hominis (1/5)
neg. major Vancomycin + Rifampicin 2 weeks then Levofloxacin + Rifampicin 4 weeks no
3 male 26.3 2 0 TKA Loose-ning after 10 years 1 <  5 630 neg. neg. 0 Staph. hominis (2/5)
Staph. epidermidis (1/5)
neg. major Flucloxacillin + Rifampicin 2 weeks then Levofloxacin + Rifampicin 4 weeks 14 months with Staph. hominis
4 fem 30.8 3 4 TKA Loose-ning after 8 years 2 16 1000 neg. neg. 2 Staph. epidermidis (2/5) neg. major Flucloxacillin + Rifampicin 2 weeks then Levofloxacin + Rifampicin 4 weeks no
5 fem. 25.1 3 1 THA Loose-ning after 10 years 2 <  5 360 neg. neg. 0 Staph. epidermidis (4/5) neg. major Flucloxacillin + Rifampicin 2 weeks then Levofloxacin + Rifampicin 4 weeks no
6 fem. 32.9 3 6 THA Loose-ning after 4 years 1 11 860 Brevi-bacillus brevis (1/5) neg. 2 Staph. epidermidis (3/5) positive major + 5 Vancomycin + Rifampicin 2 weeks then Levofloxacin + Rifampicin 4 weeks 12 months with Staph. epidermi-dis
7 male 26.5 1 0 THA Loose-ning after 10 years 1 <  5 640 neg. neg. 0 Staph. caprae (5/5) neg. major Flucloxacillin + Rifampicin 2 weeks then Levofloxacin + Rifampicin 4 weeks no
8 male 21.9 2 0 THA Loose-ning after 10 years 2 <  5 1200 neg. neg. 0 Staph. capitis (5/5)
2 Cutibac-terium agnes (5/5)
positive major + 3 Vancomycin + Rifampicin 2 weeks then Levofloxacin + Rifampicin 4 weeks 14 months with Staph. capitis
9 male 28.9 2 2 THA Loose-ning after 9 years 1 <  5 880 neg. neg. 0 Staph. epidermidis (5/5) neg. major Flucloxacillin + Rifampicin 2 weeks then Levofloxacin + Rifampicin 4 weeks no
10 male 23.5 2 1 THA Stem loose-ning after 6 years 2 <  5 1100 neg. neg. 0 Staph. epidermidis (4/5)
Staph. capitits (2/5)
neg. major Flucloxacillin + Rifampicin 2 weeks then Levofloxacin + Rifampicin 4 weeks no
11 fem. 29.6 2 1 THA Loose-ning after 8 years 5 <  5 480 neg. neg. 0 Staph. epidermidis (2/5)
Cutibac-terium agnes (2/5)
neg. major Vancomycin + Rifampicin 2 weeks then Levofloxacin + Rifampicin 4 weeks 4 months with Staph. epidermidis
  1. Pat. Patient, fem. Female, BMI Body mass index, ASA Grading of patients for surgical procedures of the American Society of Anesthesiologists [29], CCI Charlson Comorbidity Index [30], WBC White blood cell count., y Years, neg. Negative